Recurrent and refractory primary immune thrombocytopenia
Conditions
Interventions
The research group:On the basis of the original standard western medicine treatment, the subjects combined with Sheng Xuexiaoban capsules, three times a day,4 once, half an hour after the meal, a tota
Sponsors
The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1.Meet the diagnostic criteria for recurrent or refractory ITP and the TCM diagnostic criteria for purpura 2.Age was 18-70 years old 3.Person whose case data was kept intact in the 6 months before receiving the study medication 4.Informed consent for the study and good treatment compliance
Exclusion criteria
Exclusion criteria: 1. Secondary ITP 2. Allergic constitution or known allergy to the traditional Chinese medicine and western medicine used this time 3. Combined with malignant tumor, aplastic anemia, acute leukemia, sepsis and other hematological diseases 4. Patients with severe cardiovascular and cerebrovascular diseases, infection, liver function, kidney function and other abnormalities 5. Women with mental abnormalities, pregnancy and lactation 6. The absolute value of red blood cell and white blood cell count are significantly decreased 7. Patients participating in other clinical investigators
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| total effective rate;platelet count ;Bleeding score scale;Quality of life rating scale;The TCM symptom integral scale;TPO horizontal;c-mpl horizontal; | — |
Secondary
| Measure | Time frame |
|---|---|
| Machine apheresis platelet transfusion status;Lymphocyte subset levels; | — |
Countries
China
Contacts
Public ContactShi Zhexin
The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
Outcome results
None listed